1. Findings suggest: Improvement was noted in both BMI and reported physical activity although the differences did not reach statistical difference. Behavior change may be more challenging among elderly patients who are either more physically challenged or less motivated. Longer time span is need to evaluate longer term outcomes such as: risk factors reduced at preventing future cardiac events and decreased hospital readmission rates. Secondary Prevention of Patients with Heart Disease Cathy Quick, Graduate Student, PCNP Bonnie Sanderson, PhD, RN, Faculty advisor BACKGROUND METHODS PURPOSE RESULTS More the than half of all non- communicable diseases (NCD) are cardiovascular disease (CVD) in nature (AHA, 2013). CVD is the largest single contributor to global mortality that accounts for nearly half of the 36 million NCD deaths resulting in $863 billion in global cost (AHA, 2013). A core set of interventions to decrease NCD has been established. Some of those interventions include: reducing salt intake, the harmful effects of excessive alcohol consumption, smoking cessation, and the benefits of increased activity (AHA, 2013). Educational session on heart disease and Life’s simple 7 assessment tool It included a pre/post BMI & pre/post physical activity measured in (days/week) In patients over 18 with known cardiac disease who were recently discharged from an acute care facility, how does focused education on medication compliance and adherence to lifestyle modifications compare to usual patient education in preventing future cardiac events or procedures? CONCLUSIONS School Logo GRAPH/TABLE/PHOTO The purpose of this project is to evaluate patient’s knowledge level of heart disease. The purpose of the “small test of change” (STOC) was to evaluate the use of the Life’s Simple 7 tool had at identifying a patient’s knowledge level of heart disease, and from that data determined how to modify their plan of care. (medication adherence, or lifestyle modifications)to prevent future cardiac events RaceNPercent White1083% Black217% GenderN% Male467 Female833 VariableMeanStd Deviation Age67.914.05 PICO Comparison Pre/Post BMI Key References: American Heart Association. (2013). Understanding the new prevention guidelines. http://www.heart.org/HEARTORG/Conditions/Understanding-the-New- Prevention-Guidelines_UCM_458155_Article.jsp Accessed July 29, 2014.http://www.heart.org/HEARTORG/Conditions/Understanding-the-New- Prevention-Guidelines_UCM_458155_Article.jsp Chowdhury, R., Khan, H., Heydon, E., Shroufi, A., Fahimi, S., Moore, C., Stricker, B., Mendis, S., Hofman, A., Mant, J. & Franco, O. (2013). Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. European Heart Journal, 34(38), 2940-2948. doi:10.1093/eurheartj/eht295 Eckel, R., Jakicic, J., Ard, J., de Jesus, J., Miller, N., Hubbard, V. & et al. (2013). 2013 AHA/ACC Guideline on lifestyle management to reduce cardiovascular risk: A report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation, (1) S77-S99. doi: 10.1161/01.cir.0000437740.48606.d1 Search Strategy Literature search included CINAHL; Cochrane Library; EBSCOhost; ERIC; MEDLINE; the American Heart Association. 1 clinical practice guidelines (CPG) 4 systematic reviews, 2 single studies and expert committee reviews on CVD, medication compliance, and lifestyle modifications. Summary of Evidence EBP Recommendations 1. Include lifestyle modification, education and support for patients with CHD and associated risk factors. (Grade A) 2. Assess for medication adherence and implement strategies to improve medication when indicated. (Grade A) 3. Women with CHD may require alternate strategies to meet their secondary prevention goals (Grade B) Evaluation SPSS was used for data analyses for descriptive and outcome measures. Paired t-tests were applied to evaluate pre to post differences in mean values for BMI and days of physical activity reported.